Should discounts be provided for the elimination of comorbidities or for multiple medications associated with diabetes and obesity
This formulation provides a continuous release of medication throughout the day, helping to manage symptoms effectively without the need for multiple doses
GLP-1s can help reduce appetite and increase fullness signals, but normal hunger should still exist
Depending on the drug, it may also lower cardiovascular risk or the likelihood of kidney complications in those with type 2 diabetes, ease heart failure symptoms, reduce liver fat, improve metabolic dysfunction, and lessen the severity of sleep apnea
one MD can collaborate with 4 NPs Physician Requirements: Prescription blanks must include both CRNP name and collaborating physician name Physician must review sample of charts regularly Weight-Loss Prescribing: No PA-specific obesity drug rules Follow standard of care Collaborative agreement should specify authority to prescribe weight-loss meds Telehealth: Relatively open to telehealth No comprehensive parity statute (yet) Act 69 (2020): Tele-mental health payment parity No state restrictions on controlled substance prescribing via telehealth Medicaid reimburses telehealth Bottom line: PA requires physician collaboration for all NPs